The influence of levodopa, entacapone and homocysteine on prevalence of polyneuropathy in patients with Parkinson's disease

J Neurol Sci. 2018 Sep 15:392:28-31. doi: 10.1016/j.jns.2018.06.012. Epub 2018 Jun 20.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antiparkinson Agents / therapeutic use*
  • Case-Control Studies
  • Catechols / therapeutic use*
  • Female
  • Homocysteine / blood*
  • Humans
  • Levodopa / therapeutic use*
  • Male
  • Middle Aged
  • Nitriles / therapeutic use*
  • Parkinson Disease* / blood
  • Parkinson Disease* / complications
  • Parkinson Disease* / drug therapy
  • Parkinson Disease* / epidemiology
  • Polyneuropathies* / blood
  • Polyneuropathies* / complications
  • Polyneuropathies* / epidemiology
  • Polyneuropathies* / prevention & control
  • Statistics, Nonparametric

Substances

  • Antiparkinson Agents
  • Catechols
  • Nitriles
  • Homocysteine
  • Levodopa
  • entacapone